Evidence map›Paper›PMID 36319965›Full record

ArticleBMC microbiology2022

Epidemiology of carbapenem-resistant Klebsiella pneumoniae ST15 of producing KPC-2, SHV-106 and CTX-M-15 in Anhui, China.

Hang Zhao, Zhien He, Yujie Li, Baolin Sun

Abstract read
In one paragraph

Article in BMC microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Genomic Analysis of HypervirulentIranian journal of biotechnology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Co-evolution of resistance and virulence inFrontiers in cellular and infection microbiology · 2026
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Molecular Epidemiology and In-Depth Characterization ofInternational journal of molecular sciences · 2025
    Article
  18. Article
  19. Article
  20. Deciphering vancomycin resistance inFrontiers in microbiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hang ZhaoCollege of Life Science and Technology, Mudanjiang Normal University, Mudanjiang, China.
Zhien HeDepartment of Oncology, The First Affiliated Hospital, University of Science and Technology of China, Hefei, Anhui, China. zhienhe@mail.ustc.edu.cn.
Yujie LiDepartment of Oncology, The First Affiliated Hospital, University of Science and Technology of China, Hefei, Anhui, China. lyj2020@ustc.edu.cn.
Baolin SunDepartment of Oncology, The First Affiliated Hospital, University of Science and Technology of China, Hefei, Anhui, China. sunb@ustc.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIt is well known that carbapenem-resistant Klebsiella pneumoniae (CRKP) has become a more problematic public health issue due to its widespread spread worldwide. In China, ST11-type CRKP is the most prevalent CRKP, but ST15-type CRKP, a recently prevalent high-risk clone, has emerged widely throughout China, posing a serious public health risk. Therefore, we conducted an epidemiological of an outbreak of ST15 CRKP of producing CTX-M-15, KPC-2 and SHV-106 in a tertiary hospital in Anhui, China, to Understanding the potential risks of the current STT15 CRKP outbreak.

resultsFrom July 2021 to December 2021, 13 ST15 CRKP isolates were identified by collecting non-repeated clinical multidrug-resistant isolates, with all capsular typing of serotype KL19. All ST15 CRKP isolates were resistant to cephalosporins, carbapenems and quinolones, but were sensitive to amikacin, tigecycline and polymyxin B. In addition, isolates carried bla

conclusionOur research shows that ST15 CRKP, which carries multiple β-lactamases genes and siderophores-encoding genes, may be evolving to hypervirulence and may have spread widely in localised areas. Therefore, environmental surveillance and clinical infection control in hospitals should be strengthened to prevent further spread of ST15 CRKP.

Indexed as

Carbapenem-Resistant EnterobacteriaceaeKlebsiella InfectionsAnti-Bacterial Agentsbeta-LactamasesCarbapenemsChinaHumansKlebsiella pneumoniaeMicrobial Sensitivity TestsMultilocus Sequence TypingPhylogenyTertiary Care CentersAnti-Bacterial Agentsbeta-LactamasesCarbapenemsAntibiotic resistanceCarbapenem-resistant Klebsiella pneumoniaeST15 Klebsiella pneumoniaeVirulence factorsWhole genome sequencing (WGS)β-lactams

Identifiers

PMID36319965
PMCPMC9624029

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.